Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes

Cytotoxic T lymphocytes (CTL) recognize class I major histocompatibility complex molecules complexed to peptides of eight to nine residues generated from cytosolic proteins. We find that CTL recognize, in vitro and in vivo, cells synthesizing a 10-residue peptide consisting of an initiating methionine followed by nine residues corresponding to a naturally processed determinant from influenza virus nucleoprotein (NP) (residues 147-155). Addition of two COOH-terminal residues corresponding to NP residues 157 and 158 severely reduced presentation of the endogenously produced peptide to CTL in vitro and in vivo. Extension of NH2 and COOH terminal flanking residues to include residues corresponding to NP residues 137-146 and 159-168 failed to increase the antigenicity of this peptide. Its presentation was greatly enhanced, however, by further extending the NH2 and COOH termini to include all of the additional residues of NP. These findings indicate first, that a naturally processed viral ligand (with an NH2-terminal Met) of a class I molecule contains sufficient information to access intracellular class I molecules, and second, that flanking residues can influence the processing and presentation of antigens to CTL.

[1]  G. Chimini,et al.  Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen , 1989, The Journal of experimental medicine.

[2]  A. McMichael,et al.  Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen , 1989, Nature.

[3]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[4]  J. Cossins,et al.  A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes , 1989, The Journal of experimental medicine.

[5]  B. Coupar,et al.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.

[6]  Hidde L. Ploegh,et al.  Peptide selection by MHC class I molecules , 1991, Nature.

[7]  T. Braciale,et al.  Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells , 1989, Nature.

[8]  Hans-Georg Rammensee,et al.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.

[9]  J. Yewdell,et al.  Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. , 1989, Science.

[10]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[11]  J. Monaco,et al.  MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.

[12]  F Sherman,et al.  The specificities of yeast methionine aminopeptidase and acetylation of amino-terminal methionine in vivo. Processing of altered iso-1-cytochromes c created by oligonucleotide transformation. , 1990, The Journal of biological chemistry.

[13]  R. Demars,et al.  A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway , 1990, Nature.

[14]  Hans-Georg Rammensee,et al.  Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.

[15]  R. Webster,et al.  DISQUISITIONS ON ORIGINAL ANTIGENIC SIN , 1966, The Journal of experimental medicine.

[16]  B. Moss,et al.  Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles , 1988, The Journal of experimental medicine.

[17]  M. Bevan,et al.  Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. , 1989, Journal of immunology.

[18]  U. Koszinowski,et al.  Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.

[19]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[20]  J. Whitton,et al.  Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes , 1989, The Journal of experimental medicine.

[21]  B. Moss,et al.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes , 1986, Journal of virology.

[22]  J. Bonifacino,et al.  Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation , 1989, Nature.

[23]  B. Coupar,et al.  Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response , 1986, European journal of immunology.

[24]  B. Moss,et al.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques , 1985, Molecular and cellular biology.

[25]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[26]  M. Bevan,et al.  Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization , 1989, The Journal of experimental medicine.

[27]  B. Moss,et al.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[29]  J. Yewdell,et al.  Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. , 1990, Science.

[30]  M. Kozak The scanning model for translation: an update , 1989, The Journal of cell biology.

[31]  T. Braciale,et al.  Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product , 1991, The Journal of experimental medicine.

[32]  J. Monaco,et al.  Transport protein genes in the murine MHC: possible implications for antigen processing. , 1990, Science.

[33]  S. Weissman,et al.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. , 1983, Virology.

[34]  R. Webster,et al.  Disquisitions of Original Antigenic Sin. I. Evidence in man. , 1966, The Journal of experimental medicine.

[35]  J. Rothbard,et al.  Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein , 1988, Cell.